Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Schwenkglenks, M; Pettengell, R; Jackisch, C; Paridaens, R; Constenla, M; Bosly, A; Szucs, T D; Leonard, R (2011). Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study. Supportive Care in Cancer, 19(4):483-490.

Mouridsen, H; Giobbie-Hurder, A; Goldhirsch, A; Thürlimann, B; Paridaens, R; Smith, I; Mauriac, L; Forbes, J F; Price, K N; Regan, M M; Gelber, R D; Coates, A S (2009). Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer. New England Journal of Medicine, 361(8):766-776.

Pettengell, R; Bosly, A; Szucs, T D; Jackisch, C; Leonard, R; Paridaens, R; Constenla, M; Schwenkglenks, M (2008). Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study. British Journal of Haematology, 144(5):677-685.

Pettengell, R; Schwenkglenks, M; Leonard, R; Bosly, A; Paridaens, R; Constenla, M; Szucs, T D; Jackisch, C (2008). Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study. Supportive Care in Cancer, 16(11):1299-1309.

Schwenkglenks, M; Jackisch, C; Constenla, M; Kerger, J N; Paridaens, R; Auerbach, L; Bosly, A; Pettengell, R; Szucs, T D; Leonard, R (2006). Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment. Supportive Care in Cancer, 14(9):901-909.

This list was generated on Sat Jul 20 01:46:46 2019 CEST.